Passionately, we aim to lead and bring innovative and
cost-effective products to emerging markets and improve patient’s lives
through long-term strategic partnerships with originators
Focus on innovation and drug development partners
Formiica’s vision was started by
WuXi AppTec is a global company with global operations across, providing integrated solutions including drug chemistry, biology discovery, preclinical testing, clinical research, and cell & gene therapy manufacturing
Has leading presence in the APAC market with over 36,000 employees, 34,000+ scientists, 31 sites, and a market capitalization of around US$50 billion
Has a successful track record of helping over 5,600 companies globally with commercialization process
UOB Venture Management (UOBVM) has presence in four countries with AUM of US$1.6 bn as of March 2026
Has 20 years of venture capital and PE investment experience, and closed 45 exits of portfolio companies in APAC in the past 15 years
Current State
- Acquisition of companies leveraging on the existing product line and market reputation to penetrate Thailand and other key countries in Southeast Asia
- In-license, register and launch targeted products for Thailand and other markets in Southeast Asia.
- Drive organic growth by collaborating with Nippon Kayaku & CBC to establish a presence in Japan
Intermediate State
- Develop pipeline of products in existing therapeutic areas (i.e. Cardiovascular, Diabetes & Oncology)
- Launch innovative biologicals across Japan, South Korea, Australia & Southeast Asia
- Established regulatory footprint in Thailand with first product approved and additional products under registration
Future State
- Expand into other therapeutic areas including Neurology
- Explore partnerships / joint ventures in Middle East and LATAM